
The panel concludes with Danielle Hicks sharing where viewers can go to learn more about the information and resources discussed in the panel, including safety information. Sponsored by Bristol Myers Squibb.

The panel concludes with Danielle Hicks sharing where viewers can go to learn more about the information and resources discussed in the panel, including safety information. Sponsored by Bristol Myers Squibb.

Danielle Hicks, a patient advocate, details her journey as a caregiver for her mother and provides advice for other caring for loved ones with lung cancer. Sponsored by Bristol Myers Squibb.

Danielle Hicks, Nisha Mohindra, MD, and Christopher Towe, MD, share their perspectives and offer advice to those navigating an early-stage non-small cell lung cancer diagnosis. Sponsored by Bristol Myers Squibb.

Nisha Mohindra, MD, and Christopher Towe, MD, define the term “multidisciplinary team” and explain why early-stage NSCLC care requires a diverse group of specialists. They also discuss the function and value of this collaborative model in guiding treatment plans. Sponsored by Bristol Myers Squibb.

The panel shares insights on the progress in early-stage non-small cell lung cancer treatment and the potential role of neoadjuvant therapy. Sponsored by Bristol Myers Squibb.

Nisha Mohindra, MD, and Christopher Towe, MD, discuss what early-stage non-small cell lung cancer treatment options have looked like in the past and a more recent treatment option, neoadjuvant therapy. Sponsored by Bristol Myers Squibb.

After Danielle Hicks introduces the panelists, Nisha Mohindra, MD, and Christopher Towe, MD, provide an overview of what an early-stage non-small cell lung cancer diagnosis means and how it is diagnosed. Sponsored by Bristol Myers Squibb.